Angiotensin-converting Enzyme 2 and Covid
Coronaviruses belong to a family of viruses that cause infections in humans and animals. The novel coronavirus (SARS-CoV-2) responsible for the Covid-19 pandemic has brought the world to a standstill. It is a highly infectious respiratory illness that has affected millions of people worldwide. Researchers are hard at work searching for treatments and solutions that can help combat the spread of the virus. One of the key areas of research is centered around angiotensin-converting enzyme 2 (ACE2), a protein found on the surface of many human cells. ACE2 plays an important role in regulating blood pressure and maintaining fluid and electrolyte balance in the body. The coronavirus uses ACE2 as a receptor to enter human cells and infect them. When an infected person coughs or sneezes, tiny droplets containing the virus can be transmitted to other people, leading to the spread of the disease. Scientists are researching the possibility of blocking ACE2 with the aim of preventing the virus from entering human cells. One of the drugs currently being explored for this purpose is called recombinant human ACE2 (rhACE2). This drug has shown promising results in pre-clinical trials and could potentially prevent the virus from using ACE2 to enter human cells. Research into ACE2 and Covid-19 is ongoing, and scientists are learning more every day about how the virus interacts with the human body. Understanding the role of ACE2 in the disease has the potential to unlock new treatments and prevention strategies, which are critical in the fight against Covid-19.
←